This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Oral lichen ruber planus wide, hypothyreosis or thyroxin
K11_ORAL_LICHEN_WIDE_HYPOT_THYRO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
66417 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1896 |
6. Filter based on genotype QC (FinnGen only) |
1896 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Oral lichen ruber planus wide, hypothyreosis or thyroxin
based on the number of shared cases.
Similar with more cases:
- Lichen ruber planus, wide definition including periferal and oral lichen planus
- Hypothyroidism (congenital or acquired)
- Hypothyreosis and Thyroxine purchase for inclusion criteria
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1896 | 1633 | 263 |
| Unadjusted period prevalence (%) | 0.50 | 0.56 | 0.12 |
| Median age at first event (years) | 62.10 | 62.19 | 61.53 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1654
- Matched controls
- 16539
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03AA01
ATC
levothyroxine sodium; systemic
460.6
323.0
1640
3350
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
10.0
323.0
837
1539
L43.8
ICD-10 Finland
Other lichen planus
78.9
323.0
606
120
L43.9
ICD-10 Finland
Lichen planus, unspecified
86.8
323.0
628
116
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
64.6
323.0
449
95
L43
ICD-10 Finland
Lichen planus
56.0
252.1
299
65
D07AD01
ATC
clobetasol; topical
5.8
189.7
670
1745
D07AC01
ATC
betamethasone; topical
4.5
179.4
996
4136
EKA10
NOMESCO Finland
Biopsy of cheek
20.6
171.7
263
150
104
Kela drug reimbursment
Thyroid insufficiency
6.9
171.7
487
938
L43.0
ICD-10 Finland
Hypertrophic lichen planus
47.5
133.2
163
38
E03
ICD-10 Finland
Other hypothyroidism
6.5
121.9
351
658
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
8.6
87.4
200
260
SAA03
NOMESCO Finland
Extended examination of mouth
2.8
84.1
837
4418
E0000UV
ATC
NA
2.8
82.3
884
4868
D07AC13
ATC
mometasone; topical
2.8
76.8
694
3396
E03.89
ICD-10 Finland
Other specified hypothyroidism
6.6
74.1
202
339
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
10.0
72.1
150
164
T86
ICPC
Hypothyroidism/myxoedema
5.6
64.2
201
400
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
63.6
451
1846
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
9.5
61.7
131
148
D07AB02
ATC
hydrocortisone butyrate; topical
2.5
60.7
646
3353
L43.3
ICD-10 Finland
Subacute (active) lichen planus
59.9
59.0
69
12
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.5
57.7
607
3109
SAA01
NOMESCO Finland
Simple examination of mouth
2.4
55.5
1261
9386
SAA02
NOMESCO Finland
Basic examination of mouth
2.3
51.9
1140
8179
SBA00
NOMESCO Finland
Microbiological examinations
6.6
50.9
137
223
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.3
47.9
274
943
K13.78
ICD-10 Finland
Other change in the oral mucosa
8.1
47.2
110
145
A07AA02
ATC
nystatin; oral
3.7
46.2
224
679
ECA20
NOMESCO Finland
Biopsy of gingiva
10.5
44.2
88
88
K13.29
ICD-10 Finland
Indefinite leukoplakia
11.0
43.3
84
80
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
43.3
661
3915
SXA10
NOMESCO Finland
Epithel biopsy of mouth
12.0
42.0
78
68
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
2.0
39.6
843
5653
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
38.6
940
6613
A01AC01
ATC
triamcinolone; local oral
7.6
38.6
93
129
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
6.7
36.9
97
153
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
35.1
472
2592
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
34.0
974
7121
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.9
33.2
979
7203
WX110
NOMESCO Finland
Local anesthesy
1.9
32.8
1164
9128
E000001
ATC
NA
2.2
32.2
410
2184
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.9
30.5
134
370
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
4.1
29.5
121
314
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.4
29.5
111
266
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.7
29.4
223
908
R01AD11
ATC
triamcinolone; nasal
2.7
29.4
219
883
Z01.2
ICD-10 Finland
Dental examination
1.8
29.2
720
4898
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.9
28.9
654
4316
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
28.7
560
3505
D82
ICPC
Teeth/gum disease
1.9
28.5
590
3767
A01AB09
ATC
miconazole; local oral
2.6
28.4
234
997
J02AC01
ATC
fluconazole; systemic
1.8
28.3
817
5832
R01AD09
ATC
mometasone; nasal
1.8
28.2
806
5735
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
27.9
828
5951
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.8
27.4
754
5283
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
27.3
710
4880
K02.1
ICD-10 Finland
Caries of dentine
1.8
27.2
912
6789
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.4
26.6
137
430
L43.1
ICD-10 Finland
Bullous lichen planus
37.4
26.2
33
9
SDA02
NOMESCO Finland
Parodonthologic therapy
1.8
25.8
592
3886
R06AE07
ATC
cetirizine; oral
1.7
25.6
798
5766
L43.2
ICD-10 Finland
Lichenoid drug reaction
50.9
25.3
30
6
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
25.1
829
6080
H02AB06
ATC
prednisolone; systemic
1.7
24.6
831
6125
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
28.0
24.5
33
12
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.9
23.6
443
2700
D07AB08
ATC
desonide; topical
2.4
23.4
220
1002
WZA90
NOMESCO Finland
Other doctors statement
1.9
22.8
413
2480
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.6
22.4
179
747
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.8
22.4
449
2790
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.8
22.3
461
2893
A02BC05
ATC
esomeprazole; systemic
1.7
22.2
756
5518
K13.20
ICD-10 Finland
Idiopathic leukoplakia
14.5
22.2
37
26
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
21.8
686
4890
E000006
ATC
NA
2.5
21.5
178
756
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.8
21.5
412
2517
R03AC02
ATC
salbutamol; inhalant
1.6
21.3
897
6920
R06AX27
ATC
desloratadine; oral
1.8
21.3
473
3029
L28.0
ICD-10 Finland
Lichen simplex chronicus
10.0
21.1
42
43
D05BB02
ATC
acitretin; oral
4.6
20.8
74
168
ULA02
NOMESCO Finland
Kolposcopy
2.3
20.5
201
932
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.9
20.5
131
477
A02BC02
ATC
pantoprazole; systemic
1.7
20.4
1123
9260
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
22.7
20.4
29
13
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
9.5
19.6
40
43
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.8
19.6
440
2815
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
19.5
505
3376
XQ802
NOMESCO Finland
Epicutan test
3.2
19.2
103
334
-1
NOMESCO Finland
NA
1.7
19.1
521
3530
LEB00
NOMESCO Finland
Biopsy of vagina
4.6
19.1
67
151
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
19.0
609
4313
A02BC03
ATC
lansoprazole; oral
1.7
18.9
549
3782
R01AD08
ATC
fluticasone; nasal
1.7
18.9
501
3362
K03.64
ICD-10 Finland
Dental calculus supragingival
1.7
18.9
458
2996
D07BC01
ATC
betamethasone and antiseptics; topical
2.1
18.8
228
1162
N06AA09
ATC
amitriptyline; systemic
2.1
18.8
227
1155
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.6
18.7
1079
8889
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.9
18.4
115
412
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.2
18.0
194
940
SPAT1301
SPAT
No procedures
1.6
17.9
551
3845
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
16.7
17.9
28
17
J01AA02
ATC
doxycycline; systemic
1.7
17.8
1330
11653
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
3.4
17.6
87
266
B37.08
ICD-10 Finland
Other candidal stomatitis
8.1
17.5
39
49
KMAK
NOMESCO Finland
NA
1.6
17.4
827
6435
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
6.3
17.3
46
75
D02AE01
ATC
carbamide; topical
2.5
17.2
143
606
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.1
17.1
214
1104
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
17.0
636
4656
N02BE01
ATC
paracetamol; systemic, rectal
1.8
16.7
1449
13107
VALMI
NOMESCO Finland
NA
1.7
16.7
392
2524
M25.5
ICD-10 Finland
Pain in joint
1.6
16.5
503
3484
K12.10
ICD-10 Finland
Stomatitis NOS
11.7
16.5
30
26
H03BB01
ATC
carbimazole; oral
2.8
16.5
107
395
UJF32
NOMESCO Finland
Coloscopy
1.7
16.5
480
3283
SPAT1260
SPAT
Consultation of another employee
1.8
16.4
326
1994
J01DA01
ATC
[U] cefalexin; systemic
1.5
16.1
1029
8518
N06AX11
ATC
mirtazapine; oral
1.6
16.1
554
3958
69700
ICD-8 Finland
Lichen, Planus
48.0
16.0
19
*
J01DB01
ATC
cefalexin; oral
1.7
15.9
1331
11772
M79.6
ICD-10 Finland
Pain in limb
1.6
15.8
626
4625
L08
ICPC
Shoulder symptom/complaint
1.7
15.7
351
2220
N06AX16
ATC
venlafaxine; oral
1.9
15.7
243
1362
A01AB04
ATC
amphotericin B; local oral
2.6
15.5
119
486
S29
ICPC
Skin symptom/complaint other
1.8
15.4
310
1898
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
4.2
15.4
58
141
M01AH05
ATC
etoricoxib; oral
1.5
15.2
982
8093
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.7
15.0
409
2739
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
14.9
373
2435
S18
ICPC
Laceration/cut
1.5
14.8
704
5406
S21
ICPC
Skin texture symptom/complaint
1.9
14.6
229
1289
N06AB04
ATC
citalopram; systemic
1.7
14.5
387
2571
TQW80
NOMESCO Finland
Local dermatologic skincare
3.8
14.5
62
169
R06AE09
ATC
levocetirizine; oral
1.8
14.5
251
1462
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.4
14.0
118
507
M79.1
ICD-10 Finland
Myalgia
1.9
14.0
231
1322
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
13.9
393
2646
M03BX02
ATC
tizanidine; oral
1.5
13.8
1021
8576
SPAT1263
SPAT
Sampling
1.5
13.8
691
5340
M01AE02
ATC
naproxen; oral, rectal
1.5
13.8
918
7543
J01CA04
ATC
amoxicillin; systemic
1.6
13.7
1289
11426
D09AB01
ATC
zinc bandage without supplements; topical
4.1
13.4
52
131
C07AA05
ATC
propranolol; systemic
1.7
13.4
335
2180
R05
ICPC
Cough
1.6
13.3
386
2613
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
13.2
368
2468
N02AX02
ATC
tramadol; systemic, rectal
1.5
13.2
698
5446
WX290
NOMESCO Finland
Other blockade of nerve
1.5
13.1
616
4678
N03AX16
ATC
pregabalin; oral
1.6
13.1
423
2946
E000002
ATC
NA
1.9
12.9
190
1039
C05AA08
ATC
fluocortolone; rectal, topical
1.8
12.8
255
1548
SPAT1153
SPAT
Removal of sutures
1.5
12.8
559
4177
SFA00
NOMESCO Finland
Small filling
1.8
12.6
225
1322
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.3
12.5
63
197
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.6
12.5
92
366
A98
ICPC
Health maint/preventive medicine
2.4
12.4
1597
15213
SXC05
NOMESCO Finland
Other oral or dental procedure
2.5
12.4
99
413
L17
ICPC
Foot/toe symptom/complaint
1.6
12.4
433
3065
K30
ICD-10 Finland
Functional dyspepsia
1.9
12.4
195
1096
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
12.3
207
1186
SBB10
NOMESCO Finland
Teeth copy
2.5
12.3
98
408
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.9
12.3
201
1143
K07.60
ICD-10 Finland
Snapping jaw
2.6
12.2
91
365
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.9
12.2
192
1077
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
4.6
12.2
41
90
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.0
12.1
151
777
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
12.1
402
2811
BAA60
NOMESCO Finland
Total thyroidectomy
3.1
12.1
66
220
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
18.2
12.0
18
10
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.6
12.0
53
150
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
12.0
248
1524
XQ848
NOMESCO Finland
Dermatological photography
3.4
11.9
56
167
SXA20
NOMESCO Finland
Local application of medicine to mouth
2.5
11.9
95
396
J01FA10
ATC
azithromycin; systemic
1.4
11.9
932
7807
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
11.8
478
3494
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
11.7
703
5580
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.1
11.7
63
208
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
11.6
453
3279
B03BA03
ATC
hydroxocobalamin; parenteral
2.4
11.6
102
449
D19
ICPC
Teeth/gum symptom/complaint
1.5
11.5
402
2838
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.0
11.5
67
233
EJ2S1
NOMESCO Finland
Photography of oral mucosa
13.7
11.5
19
14
N06AX21
ATC
duloxetine; oral
1.8
11.4
199
1158
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
11.3
554
4210
K02.0
ICD-10 Finland
Caries limited to enamel
1.8
11.2
188
1079
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.6
11.2
345
2363
L15
ICPC
Knee symptom/complaint
1.6
11.1
379
2657
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
11.1
205
1212
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
11.1
134
679
N06AB10
ATC
escitalopram; oral
1.6
11.1
298
1969
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
11.0
283
1849
D06BX01
ATC
metronidazole; topical
1.8
10.9
194
1135
M54.5
ICD-10 Finland
Low back pain
1.5
10.9
525
3971
M01AX17
ATC
nimesulide; oral
1.5
10.9
433
3146
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.0
10.8
135
695
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
5.1
10.8
33
66
A02BC01
ATC
omeprazole; systemic
1.5
10.8
462
3407
SPAT1312
SPAT
General health counselling
1.5
10.8
510
3841
R06.0
ICD-10 Finland
Dyspnoea
1.5
10.8
416
3000
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
10.7
85
354
F45.8
ICD-10 Finland
Other somatoform disorders
2.2
10.7
110
522
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.7
678
5407
XQ800
NOMESCO Finland
Prick test
2.1
10.6
125
629
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.8
10.6
44
119
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.9
10.6
62
217
G44.2
ICD-10 Finland
Tension-type headache
1.7
10.6
233
1455
T89
ICPC
Diabetes insulin dependent
3.0
10.5
58
195
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
10.5
369
2599
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.7
10.5
221
1362
EBA00
NOMESCO Finland
Extraction of tooth
1.5
10.4
468
3480
R01AD12
ATC
fluticasone furoate; nasal
1.5
10.4
448
3303
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
10.4
760
6218
R13
ICD-10 Finland
Dysphagia
2.1
10.3
116
574
N05CF02
ATC
zolpidem; oral
1.6
10.3
306
2074
D07CC01
ATC
betamethasone and antibiotics; topical
1.7
10.2
206
1253
EMAK
NOMESCO Finland
NA
2.5
10.2
76
308
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
10.2
499
3775
D07XC01
ATC
betamethasone, combinations; topical
1.8
10.2
194
1161
G01AA10
ATC
clindamycin; vaginal
1.6
10.1
296
1995
K05.1
ICD-10 Finland
Chronic gingivitis
2.1
10.1
121
613
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
10.0
203
1237
R01AD01
ATC
beclometasone; nasal
1.6
10.0
266
1747
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.2
10.0
105
503
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
10.0
133
704
K12.18
ICD-10 Finland
Other forms of stomatitis
5.8
10.0
27
47
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
2.0
10.0
128
666
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
10.0
202
1232
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
9.9
200
1216
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
7.7
9.9
22
29
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
9.8
151
841
A06AD11
ATC
lactulose; oral
1.7
9.8
223
1402
SPAT1310
SPAT
Counselling related to known health issue
1.4
9.8
525
4037
B81
ICPC
Anaemia vit B12/folate deficiency
2.5
9.8
74
302
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.2
9.8
98
460
M01AX05
ATC
glucosamine; oral
1.5
9.7
408
2986
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
2.8
9.7
62
230
M01AC06
ATC
meloxicam; systemic, rectal
1.4
9.7
649
5202
R05
ICD-10 Finland
Cough
1.5
9.7
324
2254
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.8
9.6
60
217
D07AA02
ATC
hydrocortisone; topical
1.7
9.5
203
1254
N05BB01
ATC
hydroxyzine; systemic
2.1
9.5
110
547
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
9.5
228
1456
N06AB06
ATC
sertraline; oral
1.8
9.5
171
1002
R49.08
ICD-10 Finland
Other specified dysphonia
3.2
9.5
48
153
N06AB03
ATC
fluoxetine; oral
1.7
9.5
218
1376
R52.9
ICD-10 Finland
Pain, unspecified
1.9
9.5
148
830
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
9.5
326
2280
J05AB01
ATC
aciclovir; systemic
1.5
9.5
354
2524
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
9.4
257
1701
K12.00
ICD-10 Finland
Recurrent oral aphthae
4.4
9.4
33
77
M02AA07
ATC
piroxicam; topical
1.4
9.3
634
5082
L03
ICPC
Low back symptom/complaint
1.5
9.3
396
2904
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
9.6
9.3
18
19
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
6.5
9.3
23
36
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
6.1
9.2
24
40
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
9.2
96
457
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
6.7
9.1
22
33
R06AX22
ATC
ebastine; oral
1.6
9.1
292
2008
A10AE04
ATC
insulin glargine; parenteral
1.9
9.1
130
706
L30.0
ICD-10 Finland
Nummular dermatitis
2.7
9.1
61
231
N03AX09
ATC
lamotrigine; oral
2.5
9.0
69
284
J02AC02
ATC
itraconazole; systemic
1.5
9.0
309
2160
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
4.9
9.0
28
58
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
9.0
627
5044
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
9.0
1422
13220
R53
ICD-10 Finland
Malaise and fatigue
1.5
8.9
313
2200
107
Kela drug reimbursment
Pernicious anaemia
3.3
8.9
43
133
E000007
ATC
NA
2.1
8.9
96
465
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.9
8.8
51
178
TEA00
NOMESCO Finland
Biopsy of lip
4.4
8.7
30
69
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.3
8.7
76
337
J01MA02
ATC
ciprofloxacin; systemic
1.4
8.6
577
4602
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
8.6
252
1697
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
7.0
8.5
20
29
M01AB05
ATC
diclofenac; systemic, rectal
1.4
8.5
1049
9244
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
8.5
175
1070
R96
ICPC
Asthma
1.8
8.5
155
914
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
8.5
275
1896
TLE00
NOMESCO Finland
Dilatation of vagina
90.5
8.4
9
*
K05.31
ICD-10 Finland
Periodontitis pronounced
1.7
8.4
158
942
G47.3
ICD-10 Finland
Sleep apnoea
1.5
8.4
289
2020
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
8.4
207
1333
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.8
8.3
50
180
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
8.3
193
1223
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
8.3
327
2354
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.8
8.2
130
729
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
8.2
456
3507
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.9
8.2
128
716
KGH10
NOMESCO Finland
Operation for phimosis
6.5
8.2
20
31
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
6.5
8.2
20
31
H02AB04
ATC
methylprednisolone; systemic
1.6
8.1
246
1670
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
17.3
8.1
12
7
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
11.8
8.1
14
12
R74
ICPC
Upper respiratory infection acute
1.4
8.0
382
2855
H3600, E103
ICD-10 Finland
NA
6.3
8.0
20
32
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
8.0
153
917
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
8.0
308
2205
J01FF01
ATC
clindamycin; systemic
1.4
7.9
409
3100
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
7.9
112
605
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.9
654
5381
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.2
7.9
78
367
K08.80
ICD-10 Finland
Toothache NOS
1.9
7.8
119
662
D01
ICPC
Abdominal pain/cramps general
1.7
7.8
164
1010
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
7.8
596
4840
J01EA01
ATC
trimethoprim; systemic
1.4
7.7
454
3520
A10AA02
ATC
NA
2.8
7.7
46
165
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
7.7
370
2766
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
7.7
163
1005
EKB00
NOMESCO Finland
Excision of lesion of cheek
7.5
7.7
17
23
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.8
7.6
132
765
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.9
7.6
114
631
L16
ICPC
Ankle symptom/complaint
1.7
7.6
159
978
6970A
ICD-9 Finland
Lichen planus[LICHEN RUBER PLANUS]
25.1
7.6
10
*
R21
ICPC
Throat symptom/complaint
1.5
7.6
262
1828
J01FA09
ATC
clarithromycin; systemic
1.4
7.6
493
3890
R51.80
ICD-10 Finland
Headache
1.6
7.6
217
1453
N05BA04
ATC
oxazepam; oral
1.4
7.6
398
3026
N05BA01
ATC
diazepam; systemic, rectal
1.6
7.5
215
1437
R42
ICD-10 Finland
Dizziness and giddiness
1.4
7.5
355
2644
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
7.5
97
508
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.5
381
2875
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.6
7.5
174
1104
K04.08
ICD-10 Finland
Other specified pulpit
2.1
7.5
82
403
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
7.4
262
1836
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
7.4
198
1301
A04
ICPC
Weakness/tiredness general
1.6
7.4
193
1258
J01MA12
ATC
levofloxacin; systemic
1.5
7.4
264
1857
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.9
7.4
100
534
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
7.3
708
5944
UKC02
NOMESCO Finland
Cystoscopy
1.6
7.3
207
1377
N05CF01
ATC
zopiclone; oral
1.4
7.3
525
4208
R03BA01
ATC
beclometasone; inhalant
1.5
7.2
226
1542
A10AA01
ATC
NA
3.0
7.2
38
127
K13.1
ICD-10 Finland
Cheek and lip biting
7.3
7.2
16
22
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.1
7.2
36
116
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.6
7.2
30
84
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
7.2
295
2134
N77.8
ICD-10 Finland
Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
30.1
7.1
9
*
N01
ICPC
Headache
1.7
7.1
135
808
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
7.1
319
2351
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.7
7.1
136
816
L28.1
ICD-10 Finland
Prurigo nodularis
5.6
7.1
19
34
A01AB10
ATC
natamycin; local oral
2.4
7.0
57
245
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
7.0
111
627
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.7
7.0
142
868
R03BA08
ATC
ciclesonide; inhalant
1.7
7.0
142
868
K11.70
ICD-10 Finland
Hypoptyalism
4.9
7.0
21
43
K59.0
ICD-10 Finland
Constipation
1.9
6.9
93
496
L02
ICPC
Back symptom/complaint
1.7
6.9
146
904
R02
ICPC
Shortness of breath/dyspnoea
1.6
6.9
186
1226
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.7
6.9
139
847
N06AA12
ATC
doxepin; systemic
1.9
6.8
94
504
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
3.2
6.8
33
104
L13
ICPC
Hip symptom/complaint
1.5
6.8
280
2024
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
6.8
280
2025
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
6.8
96
522
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
6.8
98
538
K60.1
ICD-10 Finland
Chronic anal fissure
2.8
6.8
41
150
EHA10
NOMESCO Finland
Biopsy of palate
5.7
6.8
18
32
N03AX12
ATC
gabapentin; oral
1.5
6.8
250
1772
R03DC03
ATC
montelukast; oral
1.5
6.7
251
1779
H13
ICPC
Plugged feeling ear
1.5
6.7
263
1882
A02BC04
ATC
rabeprazole; oral
1.7
6.7
136
829
N76.1
ICD-10 Finland
Subacute and chronic vaginitis
3.2
6.7
32
100
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
6.7
203
1378
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.2
6.7
33
106
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
6.7
295
2164
S99
ICPC
Skin disease other
2.9
6.6
38
132
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
6.6
98
539
H01
ICPC
Ear pain/earache
1.7
6.6
149
936
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
6.6
624
5201
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.9
6.6
38
134
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
8.7
6.6
13
15
L01
ICPC
Neck symptom/complaint
1.5
6.5
217
1500
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
6.5
247
1756
R03BA02
ATC
budesonide; inhalant
1.4
6.5
275
2001
H92.0
ICD-10 Finland
Otalgia
2.0
6.5
77
391
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
6.5
205
1399
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.9
6.5
91
494
G43.9
ICD-10 Finland
Migraine, unspecified
2.0
6.4
77
394
L28
ICPC
Limited function/disability (L)
1.5
6.4
250
1787
A02BA02
ATC
ranitidine; systemic
1.4
6.4
319
2390
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.6
6.4
160
1032
A07EA02
ATC
hydrocortisone; rectal
2.9
6.4
37
130
K03.80
ICD-10 Finland
Irradiated enamel
2.0
6.4
76
385
K05.30
ICD-10 Finland
Periodontitis complex
1.5
6.4
191
1288
B37.0
ICD-10 Finland
Candidal stomatitis
3.5
6.4
27
77
PAD
NOMESCO Finland
NA
14.4
6.4
10
7
E000004
ATC
NA
2.7
6.4
41
154
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.9
6.3
90
490
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
6.3
156
1004
SPAT1043
SPAT
Audiometry
1.6
6.3
165
1078
S06
ICPC
Rash localized
1.9
6.3
92
507
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
6.2
64
308
S08
ICPC
Skin colour change
1.9
6.2
85
456
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
6.2
460
3689
D01BA02
ATC
terbinafine; oral; topical
1.4
6.2
351
2692
S02.51
ICD-10 Finland
Fracture of tooth, open
1.6
6.2
155
1004
K59.09
ICD-10 Finland
Constipation, unspecified
1.8
6.2
100
569
J01AA07
ATC
tetracycline; systemic
1.5
6.2
210
1462
H02AB09
ATC
hydrocortisone; systemic
2.7
6.2
40
152
D07AC14
ATC
methylprednisolone aceponate; topical
1.9
6.1
79
417
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
4.7
6.1
19
41
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
4.7
6.1
19
41
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
6.1
130
806
A10AE06
ATC
insulin degludec; parenteral
2.6
6.1
40
154
N06AX12
ATC
bupropion; oral
2.0
6.1
72
368
F34.1
ICD-10 Finland
Dysthymia
2.3
6.1
53
238
C07AB07
ATC
bisoprolol; oral
1.3
6.0
729
6261
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
6.0
123
753
K03.00
ICD-10 Finland
Approximal wear
2.0
6.0
76
398
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.7
6.0
37
138
A03FA02
ATC
cisapride; oral, rectal
1.6
6.0
136
858
N17
ICPC
Vertigo/dizziness
1.5
6.0
184
1250
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1829
13426
11.25
126.59
9.5
4.4
pmol/l
15.8
14.9
44.52
1684
12127
(3026389) Candida sp identified in Specimen by Organism specific culture
165
251
7.10
104.86
2.2
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
247
775
3.51
65.11
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1842
15585
7.39
62.00
11.3
5.3
mu/l
2.0
2.1
0.60
1693
14152
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
305
1133
3.02
60.58
3.8
3.1
pmol/l
4.3
4.4
2.38
263
997
(3000494) Fungus identified in Specimen by Culture
402
1975
2.31
44.13
1.6
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1025
7220
1.91
41.08
2.4
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
603
3682
1.94
36.20
1.4
1.3
u/ml
1.5
1.6
0.09
161
942
(3013707) Erythrocyte sedimentation rate by Westergren method
1522
12656
2.03
32.49
5.0
4.3
mm/h
13.6
13.2
0.56
1390
11658
(40768797) Stomach Pathology biopsy report
440
2538
1.96
30.48
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
252
1178
2.31
30.29
1.3
1.2
iu/ml
209.0
139.0
1.83
105
451
(3001122) Ferritin [Mass/volume] in Serum or Plasma
943
6909
1.73
29.22
3.0
2.8
ug/l
109.5
115.3
0.37
858
6346
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1139
8849
1.72
27.97
6.3
6.4
mmol/l
1.2
1.2
1.15
939
7468
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
753
5344
1.68
25.05
2.7
2.5
u/l
56.8
57.9
0.22
677
4891
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
956
7229
1.65
24.74
2.1
2.0
pmol/l
102.5
97.0
2.13
430
3387
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1035
8047
1.63
23.46
5.4
5.6
mmol/l
1.2
1.2
0.39
913
7241
(3007164) IgA [Mass/volume] in Serum or Plasma
494
3173
1.75
23.40
1.4
1.5
g/l
2.4
2.4
0.11
287
1818
(3024561) Albumin [Mass/volume] in Serum or Plasma
977
7532
1.61
22.58
4.4
4.5
g/l
35.9
35.4
2.74
899
6986
(3037522) Nuclear Ab [Titer] in Serum
376
2287
1.80
21.22
1.4
1.3
titre
579.6
555.8
0.09
98
500
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
605
4194
1.65
21.21
2.2
2.2
mg/l
2.9
3.1
0.81
517
3571
(3031040) Bacteria [#/volume] in Urine by Automated count
1336
11207
1.65
21.12
5.9
4.9
e6/l
25.4
2955.0
3.62
11
158
(3037467) Urinalysis macro (dipstick) panel - Urine
1367
11554
1.66
20.76
5.3
4.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1836
17127
3.27
20.08
19.0
16.6
mmol/l
139.6
139.7
0.96
1783
16684
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1703
15400
2.04
19.69
7.0
6.0
mmol/mol
40.4
39.8
1.47
1541
14127
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
973
7662
1.55
19.32
2.5
2.3
nmol/l
81.8
80.0
1.08
860
6821
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
54
137
4.03
19.19
1.3
1.5
u/ml
20.3
24.5
0.21
11
26
(3019309) Folate [Moles/volume] in Red Blood Cells
485
3255
1.66
18.94
1.7
1.7
nmol/l
1282.0
1186.6
1.29
350
2402
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1103
8959
1.55
18.85
6.1
6.2
umol/l
10.6
10.7
0.14
1038
8460
(3023103) Potassium [Moles/volume] in Serum or Plasma
1835
17170
3.14
18.82
19.1
16.8
mmol/l
4.0
4.0
1.31
1779
16703
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1507
13207
1.69
18.34
8.3
7.7
u/l
78.0
78.7
0.26
1417
12354
(3036481) Cortisol [Moles/volume] in Serum or Plasma
278
1607
1.86
18.32
2.5
2.1
nmol/l
374.4
370.8
0.11
248
1461
(3007853) Bacteria identified in Skin by Aerobe culture
308
1838
1.81
18.30
1.7
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1027
8256
1.53
18.06
5.6
5.7
e9/l
0.0
0.0
1.27
894
7085
(3013826) Glucose [Moles/volume] in Serum or Plasma
1172
9706
1.54
17.88
4.6
4.3
mmol/l
6.7
6.7
0.31
1097
9070
(3001604) Monocytes [#/volume] in Blood
1022
8218
1.53
17.87
5.6
5.7
e9/l
0.6
0.6
1.80
891
7043
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1769
16334
2.24
17.62
16.5
14.5
mg/l
18.7
22.4
5.89
1452
12934
(3013115) Eosinophils [#/volume] in Blood
1053
8549
1.52
17.40
5.8
5.9
e9/l
0.2
0.2
2.78
932
7438
(3019198) Lymphocytes [#/volume] in Blood
1039
8413
1.52
17.37
5.6
5.8
e9/l
1.8
1.9
1.42
921
7348
(3048689) Calprotectin [Mass/mass] in Stool
320
1967
1.75
17.11
2.2
2.0
ug/g
147.3
132.6
0.22
238
1522
(3000570) Elastase.pancreatic [Mass/mass] in Stool
123
542
2.36
16.74
1.5
1.4
ug/g
257.0
293.1
1.27
71
299
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1791
16682
2.33
16.40
6.2
5.2
mmol/l
2.8
2.8
0.50
1618
15206
(3015171) Extractable nuclear Ab [Units/volume] in Serum
139
659
2.20
15.91
1.2
1.3
u/ml
4.5
1.3
—
10
53
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1757
16273
2.09
15.85
5.8
4.8
mmol/l
6.0
5.9
1.19
1585
14713
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1761
16344
2.09
15.46
5.6
4.6
mmol/l
4.7
4.8
1.71
1597
14980
(3019225) pH of Specimen
296
1856
1.70
14.58
4.3
4.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1744
16211
1.95
14.01
5.5
4.6
mmol/l
1.5
1.6
3.32
1570
14766
(3015377) Calcium [Moles/volume] in Serum or Plasma
799
6309
1.46
14.00
3.1
3.5
mmol/l
2.4
2.4
0.61
679
5471
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1201
10278
1.46
13.53
3.7
3.1
u/l
48.2
47.6
0.08
1086
9428
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
439
3100
1.54
13.17
1.3
1.3
iu/ml
30.2
37.8
0.65
146
1000
(3021960) Folate [Moles/volume] in Serum or Plasma
555
4118
1.49
13.17
1.5
1.5
nmol/l
23.0
21.7
1.21
470
3449
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
261
1628
1.70
13.03
2.3
2.1
g/l
0.2
0.2
0.21
242
1534
(3019069) Monocytes/100 leukocytes in Blood
943
7752
1.43
12.96
6.3
6.1
%
8.5
8.6
0.15
871
7200
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
106
491
2.23
12.86
1.2
1.2
u/ml
1.3
36.2
—
5
35
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
420
2952
1.54
12.83
1.3
1.2
u/ml
12.9
12.1
0.07
149
1106
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
680
5279
1.45
12.69
2.3
2.1
u/l
124.3
183.2
5.88
636
4925
(3006504) Eosinophils/100 leukocytes in Blood
937
7712
1.43
12.69
6.0
5.9
%
3.1
2.8
4.14
860
7130
(42870588) Differential panel, method unspecified - Blood
722
5671
1.44
12.64
5.8
5.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
796
6373
1.43
12.51
4.0
3.6
ng/l
284.5
119.3
0.27
534
4432
(3013650) Neutrophils [#/volume] in Blood by Automated count
1140
9736
1.43
12.44
8.3
9.2
e9/l
3.8
4.0
3.82
1004
8474
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1688
15639
1.72
12.27
4.9
4.1
mmol/l
1.3
1.3
1.49
1509
14108
(3022948) Iron [Moles/volume] in Serum or Plasma
367
2531
1.56
12.14
2.2
2.4
umol/l
13.0
12.8
0.33
333
2336
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1832
17453
2.47
12.05
13.2
11.1
u/l
25.2
24.1
2.54
1758
16783
(3022096) Basophils/100 leukocytes in Blood
912
7513
1.41
12.05
6.0
5.9
%
0.8
0.7
3.75
840
6950
(3002030) Lymphocytes/100 leukocytes in Blood
953
7916
1.41
11.98
6.1
6.0
%
29.0
28.1
2.00
874
7309
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
508
3763
1.48
11.96
1.7
1.7
pmol/l
19437801.1
31381336.0
0.24
391
3056
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
28
62
4.57
11.90
1.8
1.7
pmol/l
14.9
15.0
0.04
23
51
(3018010) Neutrophils/100 leukocytes in Blood
940
7815
1.40
11.62
5.8
5.8
%
55.9
57.1
2.51
865
7249
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
42
128
3.33
11.52
7.0
6.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
53
187
2.89
11.37
5.5
4.6
u/ml
285.1
60.3
0.60
15
52
(36660697) Celiac disease serology panel - Serum
219
1357
1.69
11.15
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
200
1218
1.72
10.84
1.3
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1073
9193
1.39
10.70
2.8
2.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
199
1215
1.71
10.69
1.6
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
137
748
1.90
10.67
2.5
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
641
5053
1.41
10.51
2.8
3.0
ng/l
917.1
1196.5
1.71
533
4306
(3013512) EKG study
655
5195
1.40
10.32
4.3
4.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
322
2235
1.53
10.21
7.2
6.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1780
16879
1.89
10.18
17.0
13.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
670
5350
1.39
10.09
3.6
3.9
ph
7.4
7.4
0.15
140
998
(3007461) Platelets [#/volume] in Blood
1859
17938
2.86
9.95
26.1
21.8
e9/l
254.6
257.4
1.10
1808
17456
(3024731) MCV [Entitic volume]
1859
17940
2.86
9.91
26.0
21.7
fl
91.3
91.3
0.03
1823
17660
(3035350) Ketones [Presence] in Urine by Test strip
965
8188
1.36
9.89
4.4
4.0
estimate
0.0
0.0
0.00
186
1485
(3035941) MCH [Entitic mass]
1859
17942
2.85
9.86
26.0
21.7
pg
30.3
30.3
0.24
1823
17660
(3026361) Erythrocytes [#/volume] in Blood
1859
17943
2.85
9.84
26.1
21.8
e12/l
4.4
4.4
0.35
1802
17400
(3010813) Leukocytes [#/volume] in Blood
1859
17944
2.84
9.82
26.1
21.8
e9/l
6.4
6.6
2.18
1801
17401
(3000963) Hemoglobin [Mass/volume] in Blood
1859
17946
2.84
9.78
26.2
21.9
g/l
132.9
132.5
0.61
1823
17668
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
448
3352
1.44
9.72
1.5
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
659
5274
1.38
9.70
3.3
3.0
mmol/l
6.4
6.6
0.52
542
4384
(3022145) Colonoscopy Study observation
285
1955
1.54
9.50
1.3
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
91
455
2.05
9.15
1.3
1.2
u/ml
4.0
3.1
0.17
12
53
(4010399)
198
1258
1.64
9.13
1.4
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
92
463
2.04
9.09
1.3
1.2
u/ml
2.5
8.2
1.46
19
94
(3012516) Albumin [Mass/volume] in Urine
635
5098
1.37
9.01
3.4
3.2
mg/l
673.9
375.5
0.56
371
2964
(3032080) INR in Blood by Coagulation assay
801
6666
1.35
9.01
7.0
8.8
inr
1.1
1.2
4.11
255
1848
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
340
2448
1.47
8.95
1.4
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
39
134
2.95
8.83
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
964
8264
1.34
8.82
5.8
5.4
estimate
0.0
0.0
0.50
185
1487
(3007566) Smooth muscle Ab [Titer] in Serum
86
428
2.06
8.77
1.2
1.1
titre
66.7
78.6
—
6
28
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1669
15653
1.55
8.76
15.1
13.7
ml/min/173m2
77.1
77.6
0.43
1420
12886
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
77
369
2.13
8.67
1.2
1.2
u/ml
1.9
4.7
—
6
29
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
479
3693
1.40
8.64
1.7
1.8
mg/l
1.0
1.2
1.15
362
2856
(3009261) Glucose [Presence] in Urine by Test strip
971
8354
1.33
8.57
4.6
4.1
estimate
0.0
0.0
1.08
189
1474
(3004789) Transferrin [Mass/volume] in Serum or Plasma
323
2323
1.47
8.52
2.2
2.4
g/l
2.4
2.3
1.43
293
2142
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
75
359
2.13
8.48
1.2
1.2
u/ml
61.9
49.0
0.26
12
48
(3025941) Bacteria identified in Stool by Culture
150
905
1.71
8.41
1.3
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
191
1229
1.62
8.37
2.6
2.8
g/l
10.3
10.3
0.08
177
1110
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
648
5270
1.35
8.31
3.2
3.2
u/l
30.4
33.5
0.98
615
4993
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
266
1855
1.50
8.16
2.3
2.7
umol/l
5.6
7.5
3.24
232
1593
(3004616) Nuclear Ab [Presence] in Serum
51
212
2.44
8.02
1.3
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
84
434
1.98
7.76
1.3
1.2
titre
1306.7
885.0
—
6
16
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
311
2266
1.45
7.62
5.5
4.8
%
33.5
33.5
0.00
203
1465
(3020682) Albumin/Creatinine [Ratio] in Urine
651
5374
1.32
7.33
4.2
3.9
mg/mmol
5.6
7.9
0.98
371
3132
(3028026) IgM [Mass/volume] in Serum or Plasma
155
983
1.63
7.21
1.5
1.8
g/l
1.5
1.4
0.40
144
882
(3029937) Albumin [Presence] in Urine by Test strip
544
4398
1.33
7.03
5.1
4.5
estimate
0.0
0.0
0.88
186
1474
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
221
1532
1.50
6.95
3.0
3.4
ng/l
80.6
83.9
0.22
168
1301
(40761535) Cells panel - Urine sediment
206
1422
1.50
6.61
3.7
3.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
168
1110
1.56
6.59
2.6
2.9
e9/l
4.1
4.0
0.22
124
851
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
904
7878
1.28
6.54
4.3
3.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
357
2737
1.37
6.46
2.7
3.1
mmol/l
0.8
0.8
0.32
326
2526
(40760892) CBC W Ordered Manual Differential panel - Blood
439
3481
1.34
6.39
4.8
4.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
149
965
1.59
6.38
2.6
2.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
84
465
1.84
6.36
2.0
1.8
iu/l
6.9
4.6
0.63
32
150
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
577
4772
1.30
6.19
1.8
1.6
mmol/l
1.4
1.4
0.00
485
3994
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
291
2172
1.40
6.17
2.3
2.5
%
21.4
21.9
0.22
234
1848
(3019150) Specific gravity of Urine by Refractometry
450
3601
1.33
6.12
5.0
4.6
kg/l
1.0
1.0
1.31
63
540
(3026493) Urate [Moles/volume] in Serum or Plasma
512
4179
1.31
6.03
2.5
2.5
umol/l
335.6
5919.7
13.30
428
3555
(3005322) IgE [Units/volume] in Serum or Plasma
154
1019
1.56
6.02
1.3
1.2
u/ml
173.4
142.8
0.27
142
925
(3024522) Salmonella sp identified in Specimen by Organism specific culture
50
238
2.13
5.83
1.5
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
491
4001
1.31
5.83
4.5
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
691
5890
1.27
5.76
3.6
3.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
49
233
2.13
5.73
1.5
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
1299
11943
1.28
5.66
4.4
3.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
50
241
2.10
5.65
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
88
513
1.75
5.65
1.7
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
17
46
3.72
5.65
2.1
1.3
ug/l
9.8
8.8
0.36
17
46
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
35
145
2.44
5.63
1.1
1.1
u/ml
70.0
40.9
—
5
13
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
101
613
1.68
5.62
2.0
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
407
3247
1.32
5.60
3.6
3.7
ng/l
415.0
250.3
0.28
286
2532
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
724
6227
1.26
5.54
4.9
4.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
169
1164
1.50
5.50
2.5
2.4
au/ml
39.4
27.8
—
6
56
(3003458) Phosphate [Moles/volume] in Serum or Plasma
282
2134
1.38
5.49
4.7
5.1
mmol/l
1.0
1.0
1.15
253
1953
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
48
233
2.09
5.35
1.5
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
43
201
2.17
5.27
1.6
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
89
532
1.71
5.25
1.5
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
48
235
2.07
5.24
1.5
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
191
1365
1.44
5.16
2.1
2.5
ml/min/173m2
66.5
64.1
0.46
92
566
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
103
645
1.63
5.10
1.5
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
48
238
2.04
5.07
1.5
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
11
23
4.80
5.01
1.0
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
424
3450
1.29
5.00
2.5
2.5
e6/l
5.5
7.0
1.81
370
2993
(3009214) Lutropin [Units/volume] in Serum or Plasma
45
219
2.08
5.00
1.3
1.2
u/l
13.8
15.8
0.25
37
175
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
105
666
1.61
4.95
2.2
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
341
2713
1.31
4.73
1.9
1.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
109
2.50
4.63
2.0
2.0
umol/l
18.6
5.8
1.22
22
68
(3045414) Leukocytes [Presence] in Urine
122
815
1.53
4.62
1.8
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
296
2320
1.33
4.56
1.9
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
26
104
2.52
4.55
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
191
1398
1.41
4.54
2.3
2.3
ug/l
5.1
6.4
0.54
157
1211
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
59
328
1.82
4.50
3.5
3.5
%
55.1
57.7
1.00
59
328
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
45
229
1.99
4.47
1.8
2.4
mg/l
33.2
27.1
—
10
61
(36304419) Bacteria [Presence] in Urine
521
4401
1.25
4.47
3.1
3.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
85
529
1.64
4.36
1.5
1.3
iu/l
28.1
36.1
1.51
77
453
(3030467) Casts [#/volume] in Urine by Automated count
535
4544
1.25
4.35
3.2
3.1
e6/l
0.2
0.5
5.36
414
3388
(3022217) INR in Platelet poor plasma by Coagulation assay
273
2136
1.32
4.26
22.0
24.0
inr
1.3
1.3
0.05
48
279
(3047181) Lactate [Moles/volume] in Blood
78
479
1.66
4.22
6.7
6.3
mmol/l
1.4
1.2
0.38
70
424
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
25
102
2.47
4.22
1.1
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
25
102
2.47
4.22
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
30
134
2.26
4.16
1.3
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
137
960
1.46
4.14
3.4
3.5
kpa
5.1
5.2
0.22
126
895
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
131
911
1.47
4.12
3.4
3.5
mmol/l
1.4
1.9
0.79
107
697
(3009343) pH of Capillary blood
135
945
1.46
4.10
3.4
3.5
ph
7.4
7.4
0.06
20
125
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
52
288
1.83
4.05
1.4
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
665
5826
1.22
3.97
3.8
3.7
e6/l
63.0
92.5
1.11
497
4026
(3004588) Protein electrophoresis panel - Serum or Plasma
165
1210
1.40
3.90
1.8
2.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
199
1505
1.36
3.90
3.6
3.7
mmol/l
1.2
1.2
0.55
175
1308
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
24
100
2.42
3.89
1.4
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
91
593
1.56
3.89
3.8
3.9
mmol/l
24.7
25.0
0.33
84
550
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
191
1437
1.37
3.87
1.5
1.7
%
1.5
1.4
0.78
163
1238
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
66
398
1.68
3.85
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
123
857
1.47
3.84
1.1
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
417
3491
1.25
3.80
2.8
3.0
mmol/l
2.4
2.5
2.47
362
3078
(3023520) Reticulocytes [#/volume] in Blood
181
1355
1.37
3.78
2.7
2.6
e9/l
75.8
71.6
0.59
142
1023
(3017446) Testosterone [Moles/volume] in Serum or Plasma
67
408
1.67
3.78
2.4
2.1
nmol/l
10.3
11.0
0.17
59
349
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
30
141
2.15
3.71
1.6
1.6
nmol/l
49.8
43.5
0.44
30
133
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
63
381
1.68
3.66
1.4
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
85
2.49
3.63
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
78
499
1.59
3.63
1.1
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
494
4234
1.23
3.60
3.6
3.7
%
94.0
93.1
0.29
468
4116
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
224
1747
1.32
3.58
2.9
3.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
70
438
1.62
3.57
1.1
1.1
u/ml
2.7
6.8
—
5
43
(3002582) Erythrocytes [#/volume] in Urine
561
4879
1.21
3.53
3.3
3.2
e6/l
36.3
69.3
1.06
445
3691
(40761536) Microorganisms panel - Urine sediment
180
1365
1.35
3.48
4.5
4.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
218
1703
1.32
3.45
1.6
1.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
16
58
2.77
3.42
1.6
1.6
ug/l
0.5
0.5
—
9
36
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
338
2796
1.25
3.41
2.7
2.7
e6/l
0.9
1.5
2.86
215
1560
(3008152) Bicarbonate [Moles/volume] in Arterial blood
137
1000
1.40
3.36
6.6
6.5
mmol/l
24.2
24.7
0.90
129
936
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
61
375
1.65
3.35
1.4
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
33
168
1.98
3.34
1.5
1.5
nmol/l
0.2
0.3
0.67
25
123
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
102
707
1.47
3.31
1.9
2.0
u/l
39.5
39.6
0.02
84
631
(3039162) Centromere protein B Ab [Units/volume] in Serum
40
219
1.84
3.28
1.2
1.2
u/ml
101.9
50.4
—
5
16
(3025159) Blasts/100 leukocytes in Blood
171
1303
1.34
3.22
3.6
4.0
%
0.1
0.3
0.52
40
312
(3021589) Normoblasts [#/volume] in Blood
812
7350
1.18
3.22
10.3
9.5
e9/l
0.0
0.0
0.29
683
5972
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
59
364
1.64
3.21
1.3
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
69
446
1.57
3.12
2.1
2.1
mg/l
10.0
12.3
1.48
62
413
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
159
1.97
3.10
4.0
2.8
%
60.8
56.7
0.56
21
100
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
227
1810
1.29
3.10
4.0
4.2
u/l
243.2
251.9
0.39
214
1704
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
24
112
2.16
3.07
1.1
1.0
mg/l
287.9
291.9
0.11
24
93
(3026782) Osmolality of Urine
378
3201
1.23
3.06
2.7
2.7
mosm/kgh2o
488.2
517.7
1.90
310
2718
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
16
62
2.59
3.04
1.9
1.7
—
—
—
0
0
(4015189)
13
45
2.90
3.02
3.4
2.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
180
1396
1.32
3.02
2.3
2.9
ng/l
188.4
186.3
0.02
166
1270
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
200
1575
1.30
3.00
2.4
2.3
u/l
38.1
38.8
0.04
167
1351
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
51
2.76
2.98
1.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
26
127
2.06
2.97
2.0
2.0
—
8.5
—
0
7
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
212
1.81
2.97
1.2
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
42
242
1.75
2.95
1.2
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
82
558
1.49
2.95
2.5
3.1
g/l
0.3
0.3
0.03
31
190
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
70
461
1.54
2.93
1.6
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
30
3.35
2.90
1.0
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
31
163
1.92
2.90
1.5
1.3
e6/l
34275.4
151894.2
0.94
22
110
(3020630) Protein [Mass/volume] in Serum or Plasma
182
1425
1.31
2.86
2.1
2.9
g/l
67.0
66.6
0.46
171
1287
(3006184) Hemoglobin [Mass/volume] in Capillary blood
56
353
1.60
2.84
2.4
2.2
g/l
133.5
127.3
1.11
36
256
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
18
77
2.35
2.82
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
18
77
2.35
2.82
1.5
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
26
131
2.00
2.76
1.1
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
170
1326
1.31
2.75
3.7
3.7
%
0.8
0.6
0.49
37
281
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
118
2.05
2.72
1.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
224
1814
1.27
2.71
2.5
2.5
%
1.9
1.8
0.45
189
1603
(40758558) Short blood count panel - Blood
499
4388
1.19
2.69
6.2
6.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
38
220
1.74
2.66
1.3
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
184
1460
1.29
2.63
1.5
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
95
682
1.41
2.62
3.5
3.7
—
—
—
0
0
(1002224) Polysomnography panel
82
573
1.45
2.61
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
20
93
2.16
2.61
1.2
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
177
1.82
2.60
1.2
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
94
676
1.41
2.57
1.3
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
94
2.14
2.55
1.2
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
174
1380
1.29
2.51
3.8
4.0
%
0.1
0.1
1.00
44
364
(3008757) Leukocyte morphology finding [Identifier] in Blood
31
172
1.82
2.51
3.0
3.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
279
1.63
2.47
1.2
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
181
1447
1.28
2.45
3.9
3.9
%
1.1
0.9
0.18
47
395
(3030313) Adrenal Ab [Titer] in Serum
5
8
6.26
2.37
1.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
61
411
1.50
2.36
1.7
1.7
e6/l
14726.6
11704.2
0.23
46
297
(3022621) pH of Urine by Test strip
149
1169
1.30
2.34
3.8
3.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
487
4319
1.17
2.34
4.4
4.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
36
214
1.70
2.33
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1502
14468
1.18
2.33
17.4
15.9
%
39.4
38.8
1.59
924
9828
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
41
2.69
2.28
1.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
38
231
1.66
2.27
2.6
2.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
20
99
2.03
2.26
1.6
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
216
1.68
2.26
1.3
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
229
1901
1.23
2.26
1.6
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
80
2.14
2.18
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
80
2.14
2.18
1.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
42
2.63
2.18
1.1
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
30
3.01
2.14
1.1
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
197
1620
1.24
2.13
6.6
6.9
%
96.5
95.8
1.35
191
1568
(4024509)
33
197
1.69
2.12
1.6
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
206
1703
1.24
2.12
1.5
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
109
1.94
2.10
1.2
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
37
2.71
2.10
4.0
2.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
74
531
1.41
2.10
2.2
2.4
—
—
—
0
0
(4035726)
201
1660
1.24
2.09
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
221
1846
1.22
2.06
6.3
6.5
mmol/l
0.9
1.3
1.04
167
1470
(3002173) Hemoglobin [Mass/volume] in Arterial blood
186
1526
1.24
2.06
7.1
7.2
g/l
119.0
119.3
0.08
179
1476
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
70
500
1.42
2.05
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
63
442
1.44
2.03
1.9
2.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
16
76
2.11
2.02
2.6
1.9
mmol/l
8.1
9.6
—
9
61
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
64
2.20
1.94
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
70
506
1.40
1.93
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
233
1972
1.21
1.92
3.0
4.0
ug/l
56.0
19.8
0.32
175
1592
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
108
837
1.31
1.91
8.6
8.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
284
2455
1.18
1.86
1.8
2.0
s
29.1
29.4
0.23
274
2377
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
16
79
2.03
1.85
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
38
245
1.56
1.85
1.2
1.3
nmol/l
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
70
512
1.38
1.82
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
153
1.71
1.80
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
45
304
1.49
1.78
1.5
1.5
—
—
—
0
0
(4062490)
26
154
1.70
1.76
2.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
49
338
1.46
1.76
1.3
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
457
4116
1.15
1.75
2.5
2.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
18
3.34
1.74
3.3
2.9
umol/l
10.0
23.1
—
6
18
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
37
241
1.55
1.74
1.1
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
74
551
1.36
1.73
2.3
3.6
mg/l
39.3
164.4
0.66
58
452
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
69
509
1.37
1.72
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
99
771
1.30
1.71
1.7
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
72
535
1.36
1.71
2.3
3.6
ratio
1.5
1.6
—
6
41
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
218
1856
1.20
1.70
6.3
6.5
kpa
5.1
5.1
0.11
209
1775
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
295
2579
1.17
1.69
2.9
2.8
e6/l
3.5
3.6
0.08
172
1350
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
34
219
1.56
1.68
1.5
1.4
%
60.5
58.8
0.09
20
138
(3040151) Glucose [Moles/volume] in Capillary blood
28
172
1.64
1.67
3.4
6.3
mmol/l
7.4
7.2
0.11
23
144
(3019832) Treponema pallidum Ab [Presence] in Serum
95
740
1.30
1.65
1.5
1.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
25
150
1.68
1.63
2.4
1.5
g/l
2.2
2.8
1.75
16
106
(3024139) IgG subclass 3 [Mass/volume] in Serum
25
150
1.68
1.63
2.4
1.5
g/l
0.3
0.4
0.53
16
107
(3027135) IgG subclass 1 [Mass/volume] in Serum
25
150
1.68
1.63
2.4
1.5
g/l
5.7
7.2
2.25
16
106
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
109
866
1.27
1.63
1.7
1.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
217
1855
1.19
1.63
6.4
6.5
kpa
12.9
12.5
0.60
209
1772
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
18
98
1.84
1.61
1.1
1.1
iu/ml
6.9
14.6
—
6
25
(3019977) pH of Arterial blood
16
84
1.91
1.59
2.4
3.1
ph
7.4
7.4
—
5
31
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
73
551
1.34
1.59
2.3
3.6
mg/l
41.1
51.4
0.29
57
451
(40760888) Immunoglobulin light chains.free panel - Serum
56
405
1.39
1.59
2.4
3.8
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
20
3.01
1.58
1.2
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
474
4309
1.13
1.57
4.0
3.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
72
544
1.34
1.56
1.9
1.7
mg/l
3.5
3.7
0.06
53
392
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
117
944
1.26
1.55
1.4
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
176
1.60
1.55
1.7
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
35
232
1.52
1.55
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
19
107
1.78
1.54
1.1
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
223
1921
1.18
1.54
1.6
1.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
54
391
1.39
1.53
2.6
3.1
mg/l
1.5
1.6
0.25
48
361
(3019060) Gas panel - Arterial blood
130
1064
1.24
1.53
5.2
4.6
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
27
2.60
1.51
2.0
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
17
94
1.82
1.47
1.4
1.5
—
62.9
—
0
7
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
209
1801
1.18
1.45
5.6
5.0
ug/l
1.8
2.7
1.63
172
1574
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
28
2.51
1.45
6.3
8.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
164
1.59
1.43
1.7
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
61
457
1.35
1.42
1.4
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
221
1919
1.17
1.40
1.7
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
67
1.95
1.38
4.0
2.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
23
2.61
1.36
1.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
143
1.62
1.35
1.7
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
143
1.62
1.35
1.7
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
143
1.62
1.35
1.7
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
25
159
1.58
1.34
1.4
1.5
%
23.3
36.3
0.93
14
95
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
76
594
1.29
1.33
1.6
1.5
—
—
—
0
0
(4094501)
60
454
1.33
1.33
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
22
136
1.62
1.32
1.1
1.1
nmol/l
443.0
397.4
0.38
17
119
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
38
266
1.44
1.32
1.1
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
89
711
1.26
1.32
2.0
1.7
g/l
1.3
1.6
1.93
73
622
(3044927) Protein electrophoresis panel - Urine
28
184
1.53
1.32
1.1
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
17
98
1.74
1.31
1.2
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
97
784
1.25
1.31
1.5
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
8
34
2.36
1.29
1.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
69
1.89
1.28
1.8
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
69
1.89
1.28
1.8
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
69
1.89
1.28
1.8
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
21
130
1.62
1.26
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
21
130
1.62
1.26
1.3
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
92
1.75
1.25
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
48
355
1.36
1.24
3.5
4.2
mmol/l
2.3
3.0
0.79
37
250
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
48
355
1.36
1.24
2.2
2.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
21
131
1.61
1.23
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
21
131
1.61
1.23
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
21
131
1.61
1.23
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
21
131
1.61
1.23
1.3
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
85
1.77
1.23
1.7
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
85
1.77
1.23
1.7
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
85
1.77
1.23
1.7
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
85
1.77
1.23
1.7
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
78
621
1.27
1.21
2.2
2.0
ug/l
2.6
2.1
0.11
62
542
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
26
2.31
1.18
1.2
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
26
2.31
1.18
1.2
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
27
181
1.50
1.18
1.4
1.3
mosm/kgh2o
278.0
274.4
0.44
21
136
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
126
1061
1.20
1.17
1.4
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
22
141
1.57
1.17
2.7
1.9
e9/l
1.3
1.1
0.27
13
83
(3002385) Erythrocyte distribution width [Ratio]
1379
13407
1.10
1.16
19.3
17.9
%
13.7
13.7
1.43
1348
13106
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
17
102
1.67
1.16
1.1
1.2
u/l
62.9
75.0
0.56
11
80
(3009015) Lactate [Moles/volume] in Synovial fluid
5
20
2.50
1.15
1.0
1.4
—
4.7
—
0
11
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(3010421) pH of Blood
56
431
1.31
1.13
3.4
3.9
ph
7.4
7.4
0.67
45
350
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
17
103
1.66
1.12
1.1
1.2
u/l
13.7
22.8
1.19
12
78
(3024980) IgG subclass 4 [Mass/volume] in Serum
34
243
1.41
1.10
2.1
1.7
g/l
0.4
0.8
3.11
23
183
(21494755) Public health laboratory ask at order entry panel
81
992
0.81
1.10
1.4
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
61
478
1.29
1.09
1.7
1.6
iu/ml
0.0
0.1
—
8
101
(3025549) Creatine [Moles/time] in 24 hour Urine
5
21
2.38
1.09
2.0
1.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
21
2.38
1.09
2.8
2.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
32
2.19
1.08
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
24
161
1.50
1.07
1.3
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
20
129
1.56
1.05
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
106
1.61
1.03
1.9
1.9
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
14
83
1.69
1.01
1.1
11.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
40
299
1.35
1.01
1.5
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
50
387
1.30
1.00
2.5
2.9
mmol/l
25.1
25.2
0.09
43
338
(3001686) Cold agglutinin [Titer] in Serum or Plasma
7
35
2.00
1.00
1.4
1.3
—
216.0
—
0
5
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
23
2.18
0.98
1.2
2.7
—
—
—
0
0
(4268621)
22
148
1.49
0.98
2.8
2.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
575
5411
1.09
0.97
2.5
2.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
51
1.77
0.94
1.0
1.1
iu/ml
130.1
211.0
—
9
51
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
29
2.07
0.89
1.2
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
29
2.07
0.89
1.0
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
57
457
1.25
0.89
1.7
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
42
1.91
0.88
1.8
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
29
211
1.38
0.88
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
50
395
1.27
0.88
1.4
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
169
1.43
0.87
1.1
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
11
64
1.72
0.86
1.1
1.2
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
11
64
1.72
0.86
1.4
1.4
umol/l
2.2
2.1
0.18
11
59
(1617658) Protocol used for examination of sentinel lymph nodes
14
216
0.65
0.86
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
44
1.82
0.86
4.0
1.9
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
44
1.82
0.86
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
44
1.82
0.86
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
44
1.82
0.86
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
44
1.82
0.86
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
45
1.78
0.84
3.6
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
45
1.78
0.84
3.6
2.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
62
507
1.23
0.83
1.3
1.3
—
—
—
0
0
(4034850)
67
553
1.22
0.82
12.6
9.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
153
1355
1.14
0.82
6.8
7.1
mmol/l
8.6
9.6
1.23
137
1294
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
28
206
1.36
0.81
2.3
2.2
pg
32.2
32.4
0.06
28
206
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
97
1.55
0.81
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
89
1.58
0.81
3.1
2.0
e6/l
934.5
705.5
—
8
44
(3037556) Urate [Mass/volume] in Serum or Plasma
10
58
1.73
0.79
1.2
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
33
1.82
0.79
2.3
1.3
ng/l
114.8
76.8
—
6
33
(3000492) Spirometry study
164
1464
1.13
0.79
1.4
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
11
66
1.67
0.78
1.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
131
1.45
0.78
1.1
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
199
0.65
0.78
1.7
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
31
234
1.33
0.77
1.5
1.3
—
—
—
0
0
(4146454)
27
200
1.36
0.76
3.1
2.9
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
9
53
1.70
0.75
1.7
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
91
1.54
0.75
2.9
2.9
—
—
—
0
0
(44813793)
17
116
1.47
0.74
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
38
1.85
0.73
1.0
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
35
272
1.29
0.73
4.4
5.2
iu/ml
712.3
304.8
—
6
39
(3021901) Oxygen saturation in Capillary blood
36
281
1.29
0.73
2.7
2.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
25
2.00
0.72
8.2
8.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
389
1.24
0.72
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
206
0.68
0.71
2.0
2.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
109
1.47
0.71
1.8
1.8
%
9.0
13.2
—
5
38
(40767503) Oxygen content in Capillary blood by calculation
42
336
1.26
0.70
2.8
2.4
%
16.9
16.0
0.94
24
169
(3002256) Pathology report gross observation
244
2244
1.10
0.70
1.3
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
88
760
1.17
0.69
2.8
3.1
mmol/l
25.1
25.5
0.65
82
741
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
13
85
1.53
0.69
1.2
1.4
mmol/l
5.9
6.0
0.12
13
80
(3005570) Glucose [Moles/volume] in Urine
24
178
1.35
0.69
2.2
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
42
338
1.25
0.68
1.4
1.3
mmol/l
50.7
59.5
1.04
30
274
(3032057) Clostridioides difficile [Presence] in Stool
7
43
1.63
0.67
2.3
2.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
14
94
1.49
0.66
1.6
1.4
u/l
13.7
13.3
0.07
14
89
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
643
1.17
0.65
2.0
2.6
g/l
9.9
10.1
0.14
61
543
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
70
1.57
0.65
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
159
1440
1.11
0.63
5.0
4.3
%
19.8
21.4
0.66
62
690
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
87
1.50
0.63
1.2
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
121
1.41
0.62
1.1
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
80
1.50
0.59
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
80
1.50
0.59
1.3
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
52
1.54
0.59
1.1
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
201
1.30
0.59
1.2
1.2
u/l
62.1
53.9
0.33
14
140
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
19
140
1.36
0.58
1.6
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
32
255
1.26
0.58
1.8
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
36
1.67
0.56
1.3
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
87
0.57
0.56
1.4
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
55
1.46
0.56
2.4
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
60
514
1.17
0.55
2.5
3.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
66
761
0.86
0.55
2.4
2.4
%
1.1
1.1
0.23
66
755
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
142
1.34
0.54
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
116
1.38
0.54
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
82
1.47
0.54
1.3
2.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
33
267
1.24
0.54
4.0
3.1
%
1.3
1.3
0.01
27
209
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
160
1.32
0.53
2.3
2.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
74
1.49
0.53
1.1
1.3
nmol/l
154.7
139.0
0.23
11
74
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
74
1.49
0.53
1.1
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
657
1.15
0.53
1.6
2.6
g/l
2.9
3.1
0.93
60
508
(3028308) Erythrocytes [#/volume] in Pleural fluid
11
158
0.69
0.52
1.7
1.3
e6/l
20131.7
104486.2
—
6
83
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
56
480
1.17
0.52
2.6
3.3
u/ml
0.3
0.4
0.34
29
292
(3011288) Drugs identified in Urine by Screen method
20
152
1.32
0.52
1.4
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
40
1.50
0.51
1.2
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
24
188
1.28
0.51
1.3
1.3
mmol/l
7.6
7.7
0.02
19
129
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
65
1.39
0.50
1.1
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
33
270
1.23
0.50
1.4
1.5
—
—
—
0
0
(44806118)
22
171
1.29
0.50
1.5
1.4
—
—
—
0
0
(44790047)
22
171
1.29
0.50
1.5
1.4
—
—
—
0
0
(44790049)
22
171
1.29
0.50
1.5
1.4
—
—
—
0
0
(44790048)
22
171
1.29
0.50
1.5
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
67
1.50
0.49
2.2
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
21
163
1.29
0.48
1.2
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
46
1.52
0.48
1.7
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
395
4138
0.94
0.48
1.5
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
48
1.46
0.46
1.7
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
40
337
1.19
0.46
4.0
3.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
112
1019
1.11
0.45
1.6
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
50
1.40
0.45
1.1
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
74
658
1.13
0.44
2.8
3.3
u/ml
73.7
934.3
2.21
61
565
(3020491) Glucose [Moles/volume] in Blood
16
121
1.33
0.44
1.3
1.6
mmol/l
6.0
6.9
—
7
81
(3043410) Blood group antigens tested for on Red Blood Cells
7
51
1.37
0.44
1.6
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
27
220
1.23
0.43
1.6
1.2
u/ml
2.8
2.0
—
8
57
(4281824)
20
252
0.79
0.43
1.2
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
239
1.22
0.42
1.1
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
56
1.43
0.42
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
221
1.22
0.42
1.1
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
44
378
1.17
0.42
2.1
2.4
ug/min
130.9
91.4
0.22
21
219
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
122
1.31
0.42
1.4
1.5
u/l
6.1
6.4
—
7
57
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
57
1.41
0.42
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
96
1.36
0.41
1.4
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
33
1.52
0.41
1.2
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(4212803)
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
46.1
—
0
9
(3020393) Adenovirus Ag [Presence] in Stool
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
41
352
1.17
0.40
1.3
1.3
e6/l
6.9
17.8
0.94
31
265
(3044242) Glucose [Moles/volume] in Arterial blood
12
88
1.37
0.40
1.3
2.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
41
353
1.17
0.39
1.4
1.4
e6/l
320.4
1005.5
0.95
35
285
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
17
133
1.28
0.38
2.2
1.8
—
1.1
—
0
6
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
67
1.34
0.38
1.4
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
12
89
1.35
0.38
2.2
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
101
926
1.10
0.37
3.5
3.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
696
1.11
0.37
2.0
2.6
g/l
3.5
3.7
1.50
60
496
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
112
0.71
0.37
1.4
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
125
1.28
0.37
2.6
2.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
72
1.39
0.37
1.2
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
697
1.11
0.36
2.0
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
697
1.11
0.36
2.0
2.6
g/l
7.4
7.5
0.12
61
521
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
67
744
0.90
0.36
1.6
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
201
0.79
0.35
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
99
1.32
0.35
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
80
0.62
0.35
1.2
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
236
1.19
0.35
1.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
28
236
1.19
0.35
1.1
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
145
0.76
0.34
1.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
237
1.18
0.33
1.1
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
32
370
0.86
0.32
5.1
3.8
mg/l
15.3
25.6
1.75
16
232
(3029075) Extractable nuclear Ab panel - Serum
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
52
1.35
0.31
1.1
1.2
%
112.4
114.7
—
7
43
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
27
230
1.18
0.31
1.4
1.3
pmol/l
322.5
287.7
0.19
20
174
(1001926) Buprenorphine [Presence] in Urine by Screen method
22
184
1.20
0.30
1.1
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
129
1.24
0.30
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
11
84
1.31
0.30
1.0
1.1
ratio
1.1
1.1
—
6
29
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
106
1136
0.93
0.29
1.7
1.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
40
354
1.13
0.29
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
40
354
1.13
0.29
1.4
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
24
204
1.18
0.28
1.1
1.1
u/ml
1.0
2.1
—
5
78
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
18
216
0.83
0.28
2.2
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
85
1.30
0.28
1.4
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
25
214
1.17
0.28
1.2
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
86
1.28
0.26
1.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
57
520
1.10
0.26
3.7
2.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
72
1.25
0.25
2.7
2.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
36
320
1.13
0.25
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
549
5365
1.03
0.25
3.2
3.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
15
181
0.83
0.25
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
85
0.70
0.24
1.0
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
211
2028
1.05
0.23
5.4
6.1
mmol/l
104.3
104.1
0.24
202
1985
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
106
1.23
0.23
1.6
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
247
1.14
0.22
3.5
1.9
u/l
20632.5
1459.1
—
8
104
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
60
555
1.08
0.22
1.5
1.5
pmol/l
83.0
241.3
3.82
60
542
(40768806) Pleura Pathology biopsy report
14
167
0.84
0.21
1.7
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.3
—
8.0
—
0
6
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
0.7
—
0
6
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025315) Body weight
0
10
0.00
0.21
0.0
5.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
363
1.10
0.21
1.3
1.2
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
20.3
—
0
12
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
37.8
—
0
12
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
7.5
—
0
12
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
18
154
1.17
0.21
1.1
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
43
1.16
0.21
2.6
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
126
1.19
0.21
1.3
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
40
439
0.91
0.20
5.1
4.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
31
278
1.12
0.20
1.5
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
0
14
0.00
0.20
0.0
1.4
—
15.6
—
0
8
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
15.2
—
0
9
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
114
0.79
0.20
1.2
1.6
umol/l
8.7
12.0
—
9
106
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
127
1.18
0.19
1.3
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
15
127
1.18
0.19
1.1
1.0
ng/l
283.6
336.7
—
9
86
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
212
1.13
0.19
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
21
184
1.14
0.19
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
21
184
1.14
0.19
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
128
1.17
0.18
1.5
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
132
0.83
0.18
2.0
2.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
15
128
1.17
0.18
1.1
1.0
ng/l
842.1
723.6
—
9
84
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
15
128
1.17
0.18
1.1
1.0
ng/l
36.1
47.9
—
9
86
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
58
1.21
0.18
1.0
1.2
miu/ml
1506.4
1779.1
—
7
58
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
38
348
1.09
0.18
1.3
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
63
1.11
0.17
3.4
5.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
129
1.16
0.17
1.5
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
15
173
0.87
0.16
1.9
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
37
340
1.09
0.16
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
70
661
1.06
0.16
4.1
4.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
20
177
1.13
0.16
1.3
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
92
1.20
0.16
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
43
399
1.08
0.16
1.5
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
40
370
1.08
0.16
3.4
3.2
nmol/l
0.8
0.8
0.09
27
288
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
47
438
1.07
0.15
2.7
2.4
g/l
3.8
3.6
0.44
42
422
(3035880) pH of Pleural fluid
6
78
0.77
0.15
1.7
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
224
0.89
0.15
2.0
2.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
161
0.87
0.15
1.1
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
7
87
0.80
0.14
1.6
2.4
—
38.4
—
0
7
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
25
227
1.10
0.14
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
256
1.10
0.14
1.8
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
12
139
0.86
0.14
1.4
1.3
mmol/l
5.9
6.5
0.47
12
131
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
96
0.83
0.13
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
132
1.14
0.13
1.5
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
107
0.84
0.13
1.3
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
58
550
1.06
0.13
1.4
2.4
g/l
38.9
37.7
0.86
53
471
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
34
317
1.07
0.12
1.1
1.7
nmol/l
0.8
0.8
0.02
25
259
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
292
0.92
0.11
1.6
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
32
343
0.93
0.11
2.6
2.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
24
221
1.09
0.11
1.8
1.3
u/ml
112.6
109.3
—
5
49
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
146
0.89
0.10
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
60
627
0.96
0.10
1.2
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
102
989
1.03
0.10
2.5
2.9
g/l
127.8
127.0
0.12
94
966
(3035320) C reactive protein [Mass/volume] in Body fluid
13
116
1.12
0.09
4.4
2.4
—
—
—
0
0
(3036489) Thrombin time
60
576
1.04
0.09
2.1
1.9
s
21.7
21.3
0.20
54
506
(3002032) Base excess in Venous blood by calculation
148
1446
1.03
0.09
2.9
3.4
mmol/l
1.7
2.0
0.45
116
1203
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
22
204
1.08
0.08
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
72
745
0.97
0.08
2.8
3.5
mmol/l
23.9
24.3
0.64
61
673
(3014599) Egg white IgE Ab [Units/volume] in Serum
5
63
0.79
0.08
1.0
1.0
—
0.4
—
0
15
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
195
1.08
0.08
1.2
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
19
205
0.93
0.08
1.1
1.1
%
127.6
118.6
0.81
19
184
(4306422)
22
205
1.07
0.08
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
76
1.05
0.07
2.1
2.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
80
0.87
0.07
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
80
0.87
0.07
1.4
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
9
85
1.06
0.07
1.0
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
101
1034
0.98
0.07
3.4
3.0
ug/l
0.6
0.8
2.41
62
678
(3014133) Dog dander IgE Ab [Units/volume] in Serum
15
138
1.09
0.06
1.1
1.0
u/ml
3.0
2.8
—
5
47
(3037756) Immunofixation for Serum or Plasma
36
376
0.96
0.06
1.8
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
139
1415
0.98
0.06
5.8
6.0
mmol/l
1.2
1.3
0.19
133
1362
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
355
0.96
0.06
1.3
1.3
miu/ml
195.9
243.0
0.36
18
160
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
385
1.04
0.05
1.3
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
129
1.09
0.05
1.7
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
188
1.06
0.05
1.1
1.1
u/ml
2.3
2.3
—
10
79
(3051611) Lipemic interference index of Serum or Plasma
21
198
1.06
0.05
2.4
3.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
218
1.06
0.05
1.7
1.2
u/ml
7.2
4.5
—
9
83
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
83
848
0.98
0.05
7.7
8.1
mmol/l
24.3
24.6
0.41
78
793
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
238
1.05
0.05
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
93
948
0.98
0.05
1.3
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
231
0.95
0.04
1.1
1.1
iu/ml
41.2
102.1
—
5
48
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
342
0.96
0.04
1.2
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
149
0.94
0.03
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
399
1.03
0.03
2.0
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
147
1455
1.01
0.03
2.9
3.3
kpa
5.9
5.8
0.33
142
1414
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
221
1.04
0.03
1.1
1.2
u/ml
213.7
274.3
0.58
12
136
(3003338) MCHC [Mass/volume]
1333
13344
1.00
0.01
22.4
19.2
g/l
331.3
330.8
1.10
1323
13253
(3027944) Amphetamines [Presence] in Urine
24
233
1.03
0.01
1.1
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
116
0.95
0.00
1.3
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
146
0.96
0.00
1.1
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
154
1.04
0.00
1.4
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
16
154
1.04
0.00
1.1
1.1
%
89.4
95.7
0.42
16
143
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
154
1.04
0.00
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
176
0.97
0.00
4.3
3.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
204
1.03
0.00
1.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
129
1296
1.00
0.00
6.7
7.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
155
1.03
0.00
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
155
1.03
0.00
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
215
0.98
0.00
1.1
1.1
u/ml
1.2
1.0
—
9
78
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
161
0.99
0.00
1.0
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
221
1.00
0.00
1.8
2.4
—
884.9
—
0
15
(3012441) Differential panel - Pleural fluid
16
156
1.03
0.00
1.6
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
14
142
0.99
0.00
1.0
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
26
258
1.01
0.00
1.3
1.2
u/l
19.3
25.4
0.38
21
222
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
108
1.02
0.00
2.2
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
107
1.03
0.00
3.3
3.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
133
0.98
0.00
1.5
1.7
%
10.9
10.9
0.00
13
133
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
16
163
0.98
0.00
1.5
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
183
0.98
0.00
1.1
1.1
u/ml
0.1
1.4
—
7
67
(4027681)
7
77
0.91
0.00
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
84
0.95
0.00
3.9
3.4
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
13.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
84
0.95
0.00
1.0
1.8
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4211845)
9
94
0.96
0.00
3.9
3.8
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
65
0.92
0.00
1.0
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
120
1.00
0.00
1.2
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.1
—
198.2
—
0
9
(3022229) Phosphate [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
20.7
—
0
6
(3006462) Nitrate [Presence] in Urine
8
86
0.93
0.00
4.0
4.0
—
—
—
0
0
(3024316) Viscosity of Plasma
0
8
0.00
0.00
0.0
1.5
—
1.9
—
0
8
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
17.3
—
0
5
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
53
0.94
0.00
1.8
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
6
66
0.91
0.00
40.8
24.4
ug/l
129.5
111.4
—
6
53
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
2.4
—
0
7
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
53
0.94
0.00
1.8
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
6
66
0.91
0.00
1.5
1.3
—
0.4
—
0
5
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
54
0.93
0.00
1.4
1.8
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
6.5
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: K11_ORAL_LICHEN_WIDE_HYPOT_THYRO – Oral lichen ruber planus wide, hypothyreosis or thyroxin
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).